{'fraction_non_alphanumeric': 0.028409090909090908, 'fraction_numerical': 0.015909090909090907, 'mean_word_length': 4.952702702702703, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Monitoring of γ‐Aminobutyric Acid in Human Cerebrospinal Fluid: Downward Revision of Previous Control Values

Summary γ-Aminobutyric acid (GABA) levels were measured by a radioreceptor assay in cerebrospinal fluid (CSF) specimens from two groups of subjects, one without evidence of neurological or psychiatric disease and one with a variety of neurological disorders for which GABA involvement is not known. Mean GABA concentrations in CSF for the two groups were 117 ± 10 and 127 ± 7.4 pmol/ml (means ± SE for 17 and 41 individuals, respectively). These values were about half of most previously reported mean CSF GABA control values, a fact which may be attributed, at least in part, to a reduction of artifactual increase in GABA levels during sampling, storing, and thawing of CSF samples and GABA analysis. Age and sex had no significant influence on CSF GABA concentration.